ARCHIVES

NCI To Broaden Support, Especially For Staff, Through Core Grants to Comprehensive Centers

This article is from The Cancer Letter archive.

Vol. 01 No. 47 | November 21, 1975

Download PDF Visit The Full Archive

Related Articles

Cancer Meetings Listed

October 24, 1997

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

February 21, 2003

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

June 5, 2009

Receipt Dates Clarified For AIDS-Cancers PA

July 4, 1997

NCI Programs: Researchers Take “Director’s Challenge” to Develop Molecular Profiles of Tumors

December 10, 1999